Fresenius receives a €400 million EIB loan to support R&D, innovation and capacity expansion across the EU

This article is brought to you in association with the European Parliament.This article is published in association with European Investment Bank. Fresenius, a global healthcare company, will receive a new €400 million loan from the European Investment Bank (EIB) to strengthen Fresenius’ European research and development (R&D) activities. The financing will be used to support expansion of Fresenius Kabi’s manufacturing of medical products and biosimilars in European […]
Go back up

The European Sting – Critical News & Insights on European Politics, Economy, Foreign Affairs, Business & Technology – europeansting.com